About the Company
We do not have any company description for DURECT CORP at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DRRX News
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript March 27, 2024 DURECT Corporation beats earnings ...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
DURECT Corporation
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated ...
DURECT Corp. Q4 Loss decreases, beats estimates
(RTTNews) - DURECT Corp. (DRRX) announced Loss for fourth quarter that decreased from the same period last year and beat the Street estimates. The company's bottom line came in at -$1.4 million ...
Q4 2023 DURECT Corp Earnings Call
Keith Lui; Senior Vice President, Business Development, Commercial, Medical Affairs; DURECT Corp Francois Brisebois; Analyst; Oppenheimer & Co., Inc. Carl Byrnes ...
Durect: Q4 Earnings Snapshot
CUPERTINO, Calif. (AP) — CUPERTINO, Calif. (AP) — Durect Corp. (DRRX) on Wednesday reported a loss of $1.4 million in its fourth quarter. The Cupertino, California-based company said it had a ...
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript
Greetings and welcome to the DURECT Corporation Full Quarter and Full Year Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session ...
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 27, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update.
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
DURECT Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.36. DRRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ...
Loading the latest forecasts...